Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer.

被引：0

作者：

Nutting, Christopher

Rooney, Keith

Foran, Bernadette

Pettit, Laura

Beasley, Matthew

Finneran, Laura

Roe, Justin

Tyler, Justine

Roques, Tom

Cook, Audrey

Petkar, Imran

Bhide, Shree

Srinivasan, Devraj

Boon, Cheng

De Winton, Emma

Frogley, Robert

Mertens, Kathrin

Emson, Marie

Hall, Emma

机构：

[1] Royal Marsden NHS Fdn Trust, London, England

[2] Belfast City Hosp, Belfast, Antrim, North Ireland

[3] Weston Pk Hosp, Sheffield, S Yorkshire, England

[4] Royal Shrewsbury Hosp, Shrewsbury, Salop, England

[5] Bristol Haematol & Oncol Ctr, Bristol, Avon, England

[6] Inst Canc Res, London, England

[7] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England

[8] Cheltenham Gen Hosp, Cheltenham, Glos, England

[9] Guys & St Thomas NHS Fdn Trust, London, England

[10] Royal Marsden Hosp, London, England

[11] Western Gen, Edinburgh, Midlothian, Scotland

[12] Worcestershire Royal Hosp, Worcester, MA USA

[13] Royal United Hosp, Bath, Avon, England

[14] Boehringer Ingelheim GmbH & Co KG, Vienna, Austria

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6508

引用

页数：2